NEUROSENSE THERAPEUTICS LTD's ticker is and the CUSIP is M74240108. A total of 10 filers reported holding NEUROSENSE THERAPEUTICS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $38,000 | – | 15,501 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 662,000 | $470,020 | 0.01% |
| MEITAV INVESTMENT HOUSE LTD | 95,000 | $67,450 | 0.00% |
| UBS Group AG | 9,665 | $6,862 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Citadel Advisors | 11,702 | $8,777 | 0.00% |
| CWM, LLC | 1,000 | $1 | 0.00% |